Novartis announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, which overshadowed a modest outlook raise. Novartis CEO Vasant Narasimham speaks with Bloomberg's Scarlet Fu on the impact of pharma tariffs.

Dell and DOE Talk Partnering on Building AI Infrastructure
10:15

Mattel CEO Ynon Kreiz Talks Toy Industry, Supply Chain
08:24

US Olympic Silver Medalist Korey Dropkin Talks Curling, Rock League
09:02